IPI LEGACY LIQUIDATION CO

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IMPLQ and buy or sell other stocks, ETFs, and their options commission-free!

About IMPLQ

Ipi Legacy Liquidation Co. is a commercial-stage biopharmaceutical company. It engages in the development and commercialization of transformative therapies for patients suffering from diseases with high unmet medical needs with an initial focus on diseases of the central nervous system. 

CEO
Leonard S. Paolillo
CEOLeonard S. Paolillo
Employees
Employees
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2008
Founded2008
Employees
Employees

IMPLQ Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.015
52 Week high$0.015
52 Week low
$0.015
52 Week low$0.015

Stock Snapshot

IPI LEGACY LIQUIDATION CO(IMPLQ) stock is priced at $0.02.

On 2026-03-12, IPI LEGACY LIQUIDATION CO(IMPLQ) stock opened at —, reached a high of —, and a low of —.

The IPI LEGACY LIQUIDATION CO(IMPLQ)'s current trading volume is 0.

During the past year, IPI LEGACY LIQUIDATION CO(IMPLQ) stock moved between $0.02 at its lowest and $0.02 at its peak.

During the past year, IPI LEGACY LIQUIDATION CO(IMPLQ) stock moved between $0.02 at its lowest and $0.02 at its peak.

People also own

Based on the portfolios of people who own IMPLQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.